Biology Reference
In-Depth Information
39.
Iurlaro M, Demontis F, Corada M, Zanetta L, Drake C, Gariboldi M, et al. VE-cadherin expression and clus-
tering maintain low levels of survivin in endothelial cells. Am J Pathol 2004;
:181
e
9.
40. Sasaki CY, Lin H, Morin PJ, Longo DL. Truncation of the extracellular region abrogrates cell contact but retains
the growth-suppressive activity of E-cadherin. Cancer Res 2000;
165
:7057
e
65.
41. Dietrich C, Scherwat J, Faust D, Oesch F. Subcellular localization of beta-catenin is regulated by cell density.
Biochem Biophys Res Commun 2002;
60
:195
e
9.
42. Gilbert SF. Developmental Biology. 7th ed. Sinauer; 2003.
43. Alberts B, Bray D, Lewis J, Raff, M, Roberts, K, Watson, JD. Molecular biology of the cell, 3rd ed. Garland;
1994.
44. Pollard TD, Earnshaw WC. Cell Biology. Saunders; 2002. pp. 725
e
765.
45. Gardner LB, Li F, Yang X, Dang CV. Anoxic fibroblasts activate a replication checkpoint that is bypassed by
E1a. Mol Cell Biol 2003;
292
:9032
e
45.
46. Schmaltz C, Hardenbergh PH, Wells A, Fisher DE. Regulation of proliferation-survival decisions during tumor
cell hypoxia. Mol Cell Biol 1998;
23
:2845
e
54.
47. Cockman ME, Masson N, Mole DR, Jaakkola P, Chang GW, Clifford SC, et al. Hypoxia inducible factor-alpha
binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein. J Biol Chem 2000;
18
275
:
25733
e
41.
48. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, et al. The tumour suppressor
protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999;
:271
e
5.
49. Goda N, Ryan HE, Khadivi B, McNulty W, Rickert RC, Johnson RS. Hypoxia-inducible factor 1 alpha is
essential for cell cycle arrest during hypoxia. Mol Cell Biol 2003;
399
:359
e
69.
50. Krtolica A, Krucher NA, Ludlow JW. Hypoxia-induced pRB hypophosphorylation results from down-
regulation of CDK and upregulation of PP1 activities. Oncogene 1998;
23
:2295
e
304.
51. Liu Y, Cox SR, Morita T, Kourembanas S. Hypoxia regulates vascular endothelial growth factor gene
expression in endothelial cells. Identification of a 5 enhancer. Circ Res 1995;
17
:638
e
43.
52. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, et al. Activation of vascular endothelial growth
factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 1996;
77
:4604
e
13.
53. Millauer B, Wizigmann-Voos S, Schnurch H, Martinez R, Moller NP, Risau W, et al. High affinity VEGF binding
and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell
1993;
16
:835
e
46.
54. Yu Y, Sato JD. MAP kinases, phosphatidylinositol 3-kinase, and p70 S6 kinase mediate the mitogenic response
of human endothelial cells to vascular endothelial growth factor. J Cell Physiol 1999;
72
:235
e
46.
55. Davidoff AM, Kandel JJ. Antiangiogenic therapy for the treatment of pediatric solid malignancies. Semin
Pediatr Surg 2004;
178
:53
e
60.
56. Davies JA. Branching Morphogenesis. Landes Biomedical; 2005.
57. van der Eerden BC, Karperien M, Wit JM. Systemic and local regulation of the growth plate. Endocr Rev
2003;
13
:782
e
801.
58. Nilsson A, Carlsson B, Isgaard J, Isaksson OG, Rymo L. Regulation by GH of insulin-like growth factor-I
mRNA expression in rat epiphyseal growth plate as studied with in-situ hybridization. J Endocrinol 1990;
125
24
:67
e
74.
59. Smink JJ, Koster JG, Gresnigt MG, Rooman R, Koedam JA, Buul-Offers SC. IGF and IGF-binding protein
expression in the growth plate of normal, dexamethasone-treated and human IGF-II transgenic mice.
J Endocrinol 2002;
:143
e
53.
60. Nilsson A, Isgaard J, Lindahl A, Dahlstrom A, Skottner A, Isaksson OG. Regulation by growth hormone of
number of chondrocytes containing IGF-I in rat growth plate. Science 1986;
175
:571
e
4.
61. Olney RC, Wang J, Sylvester JE, Mougey EB. Growth factor regulation of human growth plate chondrocyte
proliferation in vitro. Biochem Biophys Res Commun 2004;
233
:1171
e
82.
62. Wang J, Zhou J, Cheng CM, Kopchick JJ, Bondy CA. Evidence supporting dual, IGF-I-independent and IGF-I-
dependent, roles for GH in promoting longitudinal bone growth. J Endocrinol 2004;
317
:247
e
55.
63. Liu JL, LeRoith D. Insulin-like growth factor I is essential for postnatal growth in response to growth hormone.
Endocrinology 1999;
180
:5178
e
84.
64. Powell-Braxton L, Hollingshead P, Warburton C, Dowd M, Pitts-Meek S, Dalton D, et al. IGF-I is required for
normal embryonic growth in mice. Genes Dev 1993;
140
:2609
e
17.
7
